CA2091313A1 - Tnf-muteins - Google Patents

Tnf-muteins

Info

Publication number
CA2091313A1
CA2091313A1 CA002091313A CA2091313A CA2091313A1 CA 2091313 A1 CA2091313 A1 CA 2091313A1 CA 002091313 A CA002091313 A CA 002091313A CA 2091313 A CA2091313 A CA 2091313A CA 2091313 A1 CA2091313 A1 CA 2091313A1
Authority
CA
Canada
Prior art keywords
tnfa
mutein
tnf
dna
muteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002091313A
Other languages
English (en)
French (fr)
Inventor
Werner Lesslauer
Hansruedi Lotscher
Dietrich Stuber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2091313A1 publication Critical patent/CA2091313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002091313A 1992-04-02 1993-03-09 Tnf-muteins Abandoned CA2091313A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92810249.0 1992-04-02
EP92810249 1992-04-02

Publications (1)

Publication Number Publication Date
CA2091313A1 true CA2091313A1 (en) 1993-10-03

Family

ID=8211902

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002091313A Abandoned CA2091313A1 (en) 1992-04-02 1993-03-09 Tnf-muteins

Country Status (19)

Country Link
US (1) US5486463A (forum.php)
EP (1) EP0563714A3 (forum.php)
JP (1) JPH07285997A (forum.php)
CN (1) CN1037844C (forum.php)
AU (1) AU659927B2 (forum.php)
BR (1) BR9301420A (forum.php)
CA (1) CA2091313A1 (forum.php)
CZ (1) CZ283533B6 (forum.php)
FI (1) FI931488L (forum.php)
HU (1) HUT69790A (forum.php)
IL (1) IL105170A0 (forum.php)
MX (1) MX9301700A (forum.php)
NO (1) NO931141L (forum.php)
NZ (1) NZ247265A (forum.php)
PL (1) PL298345A1 (forum.php)
SK (1) SK376492A3 (forum.php)
TW (1) TW260707B (forum.php)
UY (1) UY23561A1 (forum.php)
ZA (1) ZA932177B (forum.php)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
CA2119089A1 (en) * 1993-03-29 1994-09-30 David Banner Tumor necrosis factor muteins
CN1049663C (zh) * 1994-09-01 2000-02-23 中国科学院上海生物工程研究中心 突变的人肿瘤坏死因子
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
PT1255558E (pt) * 2000-02-16 2006-11-30 Genentech Inc Anticorpos anti-april e células hibridoma
HUP0500992A3 (en) * 2001-08-03 2007-11-28 Genentech Inc Tacis and br3 polypeptides and uses thereof
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US20030199024A1 (en) * 2002-04-19 2003-10-23 Hansen Ted H. Single chain trimers of class I MHC molecules
WO2004011611A2 (en) * 2002-07-25 2004-02-05 Genentech, Inc. Taci antibodies and uses thereof
MXPA05005921A (es) * 2002-12-02 2005-10-19 Abgenix Inc Anticuerpos dirigidos a factor de necrosis tumoral y sus usos.
US20040121971A1 (en) * 2002-12-20 2004-06-24 Gang Chen Therapeutic use of tumor necrosis factor-alpha mutein
JP2007536896A (ja) * 2003-06-05 2007-12-20 ジェネンテック・インコーポレーテッド Ｂｌｙｓアンタゴニストとその用途
US20050163775A1 (en) * 2003-06-05 2005-07-28 Genentech, Inc. Combination therapy for B cell disorders
CN100390200C (zh) * 2003-11-24 2008-05-28 中国医学科学院基础医学研究所 一种用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
TW201122103A (en) 2004-01-06 2011-07-01 Hayashibara Biochem Lab Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
CN1752211B (zh) * 2004-09-23 2010-09-15 中国医学科学院基础医学研究所 用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
US7850960B2 (en) 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
CA2629306A1 (en) * 2005-11-23 2007-05-31 Genentech, Inc. Methods and compositions related to b cell assays
US8518697B2 (en) * 2006-04-04 2013-08-27 Washington University Single chain trimers and uses therefor
US20100316626A1 (en) * 2006-08-11 2010-12-16 The Government Of The United States Of America As Represented By The Secretary Methods for treatment and diagnosis of psychiatric disorders
WO2008127515A1 (en) * 2007-03-01 2008-10-23 Cytologic, Inc. Compositions and method for enhancing immune responses in mammals
PL2953634T3 (pl) 2013-02-07 2021-11-22 The General Hospital Corporation Sposoby namnażania lub zubożania limfocytów t-regulatorowych
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
CA3194403A1 (en) 2020-10-01 2022-04-07 Steven Josephs Reduced leaching of a ligand
WO2025163107A1 (en) 2024-02-01 2025-08-07 Institut Gustave Roussy Immune cells defective for znf217 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106158B2 (ja) * 1986-12-04 1995-11-15 サントリー株式会社 抗腫瘍活性を有する新規ポリペプチドおよびその製造法
CA2055168A1 (en) * 1990-11-21 1992-05-22 Walter Fiers Tnf-muteins

Also Published As

Publication number Publication date
ZA932177B (en) 1993-10-04
SK376492A3 (en) 1995-06-07
HUT69790A (en) 1995-09-28
CN1037844C (zh) 1998-03-25
IL105170A0 (en) 1993-07-08
CZ376492A3 (en) 1994-01-19
BR9301420A (pt) 1993-10-05
FI931488A7 (fi) 1993-10-03
NZ247265A (en) 1995-10-26
PL298345A1 (en) 1993-12-27
JPH07285997A (ja) 1995-10-31
MX9301700A (es) 1993-10-29
NO931141D0 (no) 1993-03-26
NO931141L (no) 1993-10-04
HU9300843D0 (en) 1993-06-28
FI931488A0 (fi) 1993-04-01
AU659927B2 (en) 1995-06-01
UY23561A1 (es) 1993-09-20
FI931488L (fi) 1993-10-03
EP0563714A2 (en) 1993-10-06
CZ283533B6 (cs) 1998-04-15
TW260707B (forum.php) 1995-10-21
US5486463A (en) 1996-01-23
AU3561193A (en) 1993-10-07
EP0563714A3 (en) 1993-11-10
CN1079225A (zh) 1993-12-08

Similar Documents

Publication Publication Date Title
US5486463A (en) TNF-muteins
US5597899A (en) Tumor necrosis factor muteins
US12410222B2 (en) Fusokines involving cytokines with strongly reduced receptor binding affinities
AU655948B2 (en) TNF-muteins
HU202921B (en) Process for producing coding dns for human tumor necrosis factor the corresponding polypeptide with utilizing them and pharmaceutical compositions containing this polypeptide as active component
WO1995027722A1 (en) Interleukin-15
KR100496460B1 (ko) 폴리펩티드
EP0585939B1 (en) TNF ligands
AU627477B2 (en) Interleukin ii analogs
JP3907661B2 (ja) インターフェロン−α／β結合タンパク質、その製造法およびそれを含有する医薬組成物
AU6767394A (en) Interleukin-15
Vanderspek et al. Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15
HK1252831B (en) Fusokines involving cytokines with strongly reduced receptor binding affinities
HK1225069A1 (en) Fusokines involving cytokines with strongly reduced receptor binding affinities
HK1225069B (en) Fusokines involving cytokines with strongly reduced receptor binding affinities

Legal Events

Date Code Title Description
FZDE Discontinued